Analytical Chemistry Clinical Development Disease Pharmaceuticals 
Drug Discovery World
MARCH 7, 2023
Dr Thomas has a background in biochemistry research at Leicester, Cambridge, and Glaxo, after which she has had 25 years of pharmaceutical drug discovery and development experience from large Pharma (GSK) and SMEs. Anti-ageing science therefore has huge value.
The Pharma Data
NOVEMBER 5, 2020
X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline.
Expert insights. Personalized for you.
246 
Let's personalize your content